Duration of maintenance anti-psychotic therapy after first –episode schizophrenia: a double-blind randomized placebo-control relapse prevention study

Study identifier:D1441C09906

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Duration of maintenance anti-psychotic therapy after first –episode schizophrenia: a double-blind randomized placebo-control relapse prevention study

Medical condition

schizophrenia

Phase

Phase 4

Healthy volunteers

-

Study drug

-

Sex

-

Actual Enrollment

-

Study type

Interventional

Age

-

Date

Study Start Date: 01 Aug 2003
Primary Completion Date: -
Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

-

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria